Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Circulating inflamma-miRs in aging and age-related diseases.

Olivieri F, Rippo MR, Procopio AD, Fazioli F.

Front Genet. 2013 Jun 26;4:121. doi: 10.3389/fgene.2013.00121. eCollection 2013.

2.

Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?

Cătană CS, Calin GA, Berindan-Neagoe I.

Front Med (Lausanne). 2015 Dec 15;2:85. doi: 10.3389/fmed.2015.00085. eCollection 2015. Review.

3.

MicroRNAs linking inflamm-aging, cellular senescence and cancer.

Olivieri F, Rippo MR, Monsurrò V, Salvioli S, Capri M, Procopio AD, Franceschi C.

Ageing Res Rev. 2013 Sep;12(4):1056-68. doi: 10.1016/j.arr.2013.05.001. Epub 2013 May 17. Review.

PMID:
23688930
4.

Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging.

Olivieri F, Capri M, Bonafè M, Morsiani C, Jung HJ, Spazzafumo L, Viña J, Suh Y.

Mech Ageing Dev. 2016 Dec 13. pii: S0047-6374(16)30185-3. doi: 10.1016/j.mad.2016.12.004. [Epub ahead of print] Review.

PMID:
27986629
5.

MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a.

Rippo MR, Olivieri F, Monsurrò V, Prattichizzo F, Albertini MC, Procopio AD.

Exp Gerontol. 2014 Aug;56:154-63. doi: 10.1016/j.exger.2014.03.002. Epub 2014 Mar 7. Review.

PMID:
24607549
6.

Toll like receptor signaling in "inflammaging": microRNA as new players.

Olivieri F, Rippo MR, Prattichizzo F, Babini L, Graciotti L, Recchioni R, Procopio AD.

Immun Ageing. 2013 Mar 19;10(1):11. doi: 10.1186/1742-4933-10-11.

7.

Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.

Kaur S, White S, Bartold M.

JBI Libr Syst Rev. 2012;10(42 Suppl):1-12.

PMID:
27820156
8.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

9.

Zinc and inflammatory/immune response in aging.

Vasto S, Mocchegiani E, Malavolta M, Cuppari I, Listì F, Nuzzo D, Ditta V, Candore G, Caruso C.

Ann N Y Acad Sci. 2007 Apr;1100:111-22. Review.

PMID:
17460169
10.

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.

Castro-Villegas C, Pérez-Sánchez C, Escudero A, Filipescu I, Verdu M, Ruiz-Limón P, Aguirre MA, Jiménez-Gomez Y, Font P, Rodriguez-Ariza A, Peinado JR, Collantes-Estévez E, González-Conejero R, Martinez C, Barbarroja N, López-Pedrera C.

Arthritis Res Ther. 2015 Mar 9;17:49. doi: 10.1186/s13075-015-0555-z.

11.

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C.

Int J Oncol. 2012 Dec;41(6):1897-912. doi: 10.3892/ijo.2012.1647. Epub 2012 Oct 1. Review.

PMID:
23026890
12.

MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy.

Filková M, Jüngel A, Gay RE, Gay S.

BioDrugs. 2012 Jun 1;26(3):131-41. doi: 10.2165/11631480-000000000-00000. Review.

PMID:
22494429
13.

Circulating microRNAs as biomarkers for inflammatory diseases.

Mi S, Zhang J, Zhang W, Huang RS.

Microrna. 2013;2(1):63-71. doi: 10.2174/2211536611302010007. Review.

14.

Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?

Prattichizzo F, Giuliani A, De Nigris V, Pujadas G, Ceka A, La Sala L, Genovese S, Testa R, Procopio AD, Olivieri F, Ceriello A.

Diabetes Obes Metab. 2016 Sep;18(9):855-67. doi: 10.1111/dom.12688. Epub 2016 Jun 22. Review.

15.

Circulating microRNAs in Inflammatory Bowel Diseases.

Gazouli M.

EXS. 2015;106:197-214. doi: 10.1007/978-3-0348-0955-9_9.

PMID:
26608205
16.

Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.

Grover A, Shandilya A, Punetha A, Bisaria VS, Sundar D.

BMC Genomics. 2010 Dec 2;11 Suppl 4:S25. doi: 10.1186/1471-2164-11-S4-S25.

17.

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.

Brown KD, Claudio E, Siebenlist U.

Arthritis Res Ther. 2008;10(4):212. doi: 10.1186/ar2457. Epub 2008 Aug 21. Review.

18.

Control of p53 and NF-κB signaling by WIP1 and MIF: role in cellular senescence and organismal aging.

Salminen A, Kaarniranta K.

Cell Signal. 2011 May;23(5):747-52. doi: 10.1016/j.cellsig.2010.10.012. Epub 2010 Oct 16. Review.

PMID:
20940041
19.

Redox signals and NF-kappaB activation in T cells.

Ginn-Pease ME, Whisler RL.

Free Radic Biol Med. 1998 Aug;25(3):346-61. Review.

PMID:
9680181
20.

Mechanism of attenuation of pro-inflammatory Ang II-induced NF-κB activation by genistein in the kidneys of male rats during aging.

Kim JM, Uehara Y, Choi YJ, Ha YM, Ye BH, Yu BP, Chung HY.

Biogerontology. 2011 Dec;12(6):537-50. doi: 10.1007/s10522-011-9345-4. Epub 2011 Jun 29.

PMID:
21713398

Supplemental Content

Support Center